Delivery Order SPE2DB22D3009-SPE2DB25FBD41
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $17,136.44. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed-price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 15, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, valued at $3,876.32. This firm fixed-price delivery order, which is not a set-aside contract, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, valued at $1,981.81 for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is set to be completed by August 13, 2025, and will be performed at the contractor's Conshohocken facility. The contract is funded through the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML with a ceiling value of $1,831.16. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order...
- The Defense Logistics Agency awarded a $10,788.64 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with completion scheduled for September 22, 2025. This contract utilized firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5ml quantities, with a ceiling value of $9,283.58 and a completion date of July 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.90 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with performance completion scheduled for June 4, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...